_LIMITED.webp)
British Health Products (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 22-06-2024
- Paid Up Capital ₹ 5.65 M
as on 22-06-2024
- Company Age 36 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -4.61%
(FY 2016)
- Profit 11.70%
(FY 2016)
- Ebitda 25.29%
(FY 2016)
- Net Worth 12.78%
(FY 2016)
- Total Assets -0.43%
(FY 2016)
About British Health Products (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.65 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Bhardwaj, Sanjay Agarwal, and Kawal Ratra serve as directors at the Company.
- CIN/LLPIN
U85110RJ1988PLC004308
- Company No.
004308
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Feb 1988
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Alwar, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at British Health Products (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Bhardwaj  | Director | Current | |
| Sanjay Agarwal | Director | 27-Nov-2006 | Current |
| Kawal Ratra | Director | 17-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of British Health Products (India).
British Health Products (India) Limited, for the financial year ended 2016, experienced Minor drop in revenue, with a 4.61% decrease. The company also saw a substantial improvement in profitability, with a 11.7% increase in profit. The company's net worth Soared by an impressive increase of 12.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of British Health Products (India)?
In 2017, British Health Products (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
I M B Infrastructures Private LimitedActive 15 years 2 monthsPankaj Bhardwaj and Kawal Ratra are mutual person
- Absolem Technologies Private LimitedActive 9 years 7 months
Pankaj Bhardwaj and Kawal Ratra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at British Health Products (India)?
British Health Products (India) has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of British Health Products (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped British Health Products (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
